Variability of aerosol delivery via spacer devices in young asthmatic children in daily life

被引:76
作者
Janssens, HM
Devadason, SG
Hop, WCJ
LeSouëf, PN
De Jongste, JC
Tiddens, HAWM
机构
[1] Sophia Childrens Hosp, Dept Paediat, Div Paediat Resp Med, Rotterdam, Netherlands
[2] Sophia Childrens Hosp, Dept Biostat, Rotterdam, Netherlands
[3] Erasmus Med Ctr, Rotterdam, Netherlands
[4] Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia
关键词
aerosol; asthma; budesonide; children; electrostatic charge; spacer;
D O I
10.1034/j.1399-3003.1999.13d15.x
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Pressurized metered dose inhalers (pMDI) are widely used together with spacers for the treatment of asthma in children, However, the variability of daily medication dose for pMDI/spacer combinations is not known. Electrostatic charge is a potential source of dose variability. Metal spacers have no static charge, This study assessed and compared within-subject variability of aerosol delivery of metal and plastic spacers, This was a randomized, crossover study in children with stable asthma aged 1-4 (group I, n=17) and 5-8 (group II, n=16) yrs, In both groups the amount of drug delivered to the mouth by a metal spacer (Nebuchamber(R)) and one of two plastic (polycarbonate) spacers, i.e. Babyhaler(R) in group I and Volumatici(R) in group II was measured, The metal and plastic spacers mere tested at home in a randomized order for 7 days each, using budesonide (200 mu g b.i.d.). Aerosol was collected on a filter positioned between spacer and facemask or mouth. Budesonide on the filter was assessed by high performance liquid chromatography. The mean filter dose for each child (mean+/-SD) during the 7 days was expressed as a percentage of the nominal dose. Within-subject variability was expressed as coefficient of variation (CV). Mean filter dose in group I was 41.7+/-10.1% for Nebuchamber and 26.0+/-4.0% for Babyhaler (p<0.001), Mean filter dose in group II was 50.2+/-9.2% for Nebuchamber and 19.4+/-7.2% for Volumatic (p<0.001). Mean CV in group I was 34% for Nebuchamber and 37% for Babyhaler (p=0.44), Mean CV in group II was 23% for Nebuchamber and 34% for Volumatic (p=0.003), There was substantial within-subject dose variability in aerosol delivery in children using a pMDI/spacer at home. This variability was lower for the metal than for the plastic spacer in children 5-8 yrs of age, The dose delivered to the mouth was about two-fold higher for the metal than the plastic spacer independent of age.
引用
收藏
页码:787 / 791
页数:5
相关论文
共 18 条
[1]   INFLUENCE OF SPACER DEVICE ON DRUG-DELIVERY TO YOUNG-CHILDREN WITH ASTHMA [J].
AGERTOFT, L ;
PEDERSEN, S .
ARCHIVES OF DISEASE IN CHILDHOOD, 1994, 71 (03) :217-219
[2]   Inhalational drug delivery from seven different spacer devices [J].
Barry, PW ;
OCallaghan, C .
THORAX, 1996, 51 (08) :835-840
[3]   THE EFFECT OF DELAY, MULTIPLE ACTUATIONS AND SPACER STATIC CHARGE ON THE IN-VITRO DELIVERY OF BUDESONIDE FROM THE NEBUHALER [J].
BARRY, PW ;
OCALLAGHAN, C .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 40 (01) :76-78
[4]   MULTIPLE ACTUATIONS OF SALBUTAMOL MDI INTO A SPACER DEVICE REDUCE THE AMOUNT OF DRUG RECOVERED IN THE RESPIRABLE RANGE [J].
BARRY, PW ;
OCALLAGHAN, C .
EUROPEAN RESPIRATORY JOURNAL, 1994, 7 (09) :1707-1709
[5]   IN-VITRO PROPERTIES OF PRESSURIZED METERED-DOSE INHALERS WITH AND WITHOUT SPACER DEVICES [J].
BERG, E .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 1995, 8 :S3-S11
[6]  
BISGAARD H, 1995, EUR RESPIR J, V8, P856
[7]   A NONELECTROSTATIC SPACER FOR AEROSOL DELIVERY [J].
BISGAARD, H ;
ANHOJ, J ;
KLUG, B ;
BERG, E .
ARCHIVES OF DISEASE IN CHILDHOOD, 1995, 73 (03) :226-230
[8]   LOW 1ST-SPRAY DRUG CONTENT IN ALBUTEROL METERED-DOSE INHALERS [J].
CYR, TD ;
GRAHAM, SJ ;
LI, KYR ;
LOVERING, EG .
PHARMACEUTICAL RESEARCH, 1991, 8 (05) :658-660
[9]   DRUG DELIVERY FROM HOLDING CHAMBERS WITH ATTACHED FACEMASK [J].
EVERARD, ML ;
CLARK, AR ;
MILNER, AD .
ARCHIVES OF DISEASE IN CHILDHOOD, 1992, 67 (05) :580-585
[10]   FACTORS AFFECTING TOTAL AND RESPIRABLE DOSE DELIVERED BY A SALBUTAMOL METERED-DOSE INHALER [J].
EVERARD, ML ;
DEVADASON, SG ;
SUMMERS, QA ;
LESOUEF, PN .
THORAX, 1995, 50 (07) :746-749